Stage IIIA Uterine Corpus Cancer Recruiting Phase 1 Trials for MK-1775 (DB11740)

IndicationStatusPhase
DBCOND0039113 (Stage IIIA Uterine Corpus Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03345784Adavosertib, External Beam Radiation Therapy, and Cisplatin in Treating Patients With Cervical, Vaginal, or Uterine CancerTreatment